Genetic variations in the CAT enzyme may modulate disease risk.11 Several studies have suggested that CAT polymorphisms might be associated with a risk of various cancers such as breast cancer,20 cervical cancer,21 prostate cancer,22 pancreatic cancer,23 and colorectal cancer.24 This evidence concerns the gene CAT and prostate carcinoma.